These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26100678)

  • 1. Interaction between periodontal disease and atherosclerotic vascular disease--Fact or fiction?
    Aarabi G; Eberhard J; Reissmann DR; Heydecke G; Seedorf U
    Atherosclerosis; 2015 Aug; 241(2):555-60. PubMed ID: 26100678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.
    Lockhart PB; Bolger AF; Papapanou PN; Osinbowale O; Trevisan M; Levison ME; Taubert KA; Newburger JW; Gornik HL; Gewitz MH; Wilson WR; Smith SC; Baddour LM;
    Circulation; 2012 May; 125(20):2520-44. PubMed ID: 22514251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Links between atherosclerotic and periodontal disease.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Exp Mol Pathol; 2016 Feb; 100(1):220-35. PubMed ID: 26777261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in the association between periodontal diseases and cardiovascular disease.
    Teles R; Wang CY
    Oral Dis; 2011 Jul; 17(5):450-61. PubMed ID: 21223455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
    Clearfield MB
    J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and oral disease interactions: what is the evidence?
    Ford PJ; Yamazaki K; Seymour GJ
    Prim Dent Care; 2007 Apr; 14(2):59-66. PubMed ID: 17462139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between periodontal disease and acute myocardial infarction.
    Emingil G; Buduneli E; Aliyev A; Akilli A; Atilla G
    J Periodontol; 2000 Dec; 71(12):1882-6. PubMed ID: 11156045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of destructive periodontal disease to the acute-phase response.
    Craig RG; Yip JK; So MK; Boylan RJ; Socransky SS; Haffajee AD
    J Periodontol; 2003 Jul; 74(7):1007-16. PubMed ID: 12931763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating periodontal risk for patients at risk of or suffering from atherosclerosis: recent biological hypotheses and therapeutic consequences.
    Huck O; Saadi-Thiers K; Tenenbaum H; Davideau JL; Romagna C; Laurent Y; Cottin Y; Roul JG
    Arch Cardiovasc Dis; 2011 May; 104(5):352-8. PubMed ID: 21693372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.
    De Lorenzo F; Collot-Teixeira S; Boffito M; Feher M; Gazzard B; McGregor JL
    Curr Med Chem; 2008; 15(28):2991-9. PubMed ID: 19075647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodontal disease as a risk factor for cardiovascular disease: suggestion of a further link in systemic lupus erythematosus.
    Pessoa L; Galvão V; Santos-Neto L
    Med Hypotheses; 2011 Aug; 77(2):286-9. PubMed ID: 21601991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between chronic renal disease and periodontal disease.
    Craig RG
    Oral Dis; 2008 Jan; 14(1):1-7. PubMed ID: 18173441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The association between oral diseases and stroke].
    Jelito-Barglik K; Pierzchała K; Postek-Stefańska L; Pierzchała B; Labuz-Roszak B
    Wiad Lek; 2014; 67(4):554-7. PubMed ID: 26030963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, cardiovascular disease and destructive periodontal diseases. The evolving role of the dental profession.
    Craig RG
    N Y State Dent J; 2004; 70(5):22-6. PubMed ID: 15332563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.